Literature DB >> 2409284

Clinical and haematological evaluation of beta thalassaemia intermedia characterised by unusually low Hb F and increased Hb A2: beta thalassaemia intermedia II.

A Gurgey, S Kayin, E Kansu, C Altay.   

Abstract

A total of 15 patients from different families with thalassaemia intermedia was studied. Haematological studies showed that the fetal haemoglobin was only slightly raised, being between 2 and 11.5% of the total haemoglobin. Haemoglobin A2 was high in all cases. The family study indicated that homozygosity or compound heterozygosity for beta thalassaemia was present in five patients, while dominant inheritance was observed in three. In seven patients family studies were not sufficient to predict the genotype. Haematological findings in the parents of the homozygous patients were as severe as those seen in common Hb A2 beta thalassaemia traits. The decrease in MCH and MCV was more severe and the Hb A2 higher in homozygous patients than in cases of common beta thalassaemia major (p less than 0.01, p less than 0.01, and p less than 0.001 respectively). The imbalance in in vitro globin synthesis was more severe in classical beta thalassaemia major than in homozygous patients in this study (p less than 0.01). However, the imbalance in alpha/non-alpha synthetic ratios showed variation among the homozygous and heterozygous patients in this study (2.1 to 4.0). Haematological severity and Hb F value showed some slight variation among affected persons of the same family in the case of patients with severe beta thalassaemia heterozygosity. The G gamma/A gamma ratio of haemoglobin F was found to be close to that of the adult level. Haematological studies suggested that clinical and haematological findings were more severe in patients with homozygous beta thalassaemia than in patients with heterozygosity for beta thalassaemia. The prevalence of thalassaemia intermedia with low Hb F and increased Hb A2 was found to account for 3% of the Turkish beta thalassaemic patients diagnosed before the age of 8 years.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409284      PMCID: PMC1049427          DOI: 10.1136/jmg.22.3.213

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  15 in total

1.  Heterozygous beta thalassaemia of unusual severity.

Authors:  S Friedman; S Ozsoylu; R Luddy; E Schwartz
Journal:  Br J Haematol       Date:  1976-01       Impact factor: 6.998

2.  The T gamma chain of human fetal hemoglobin at birth and in several abnormal hematologic conditions.

Authors:  T H Huisman; W A Schroeder; A Reese; J B Wilson; H Lam; R Shelton; J B Shelton; S Baker
Journal:  Pediatr Res       Date:  1977-10       Impact factor: 3.756

3.  The Thalassaemia syndromes. V. Cooley's anaemia with low level of fetal haemoglobin. A genetic study in four families.

Authors:  M Aksoy; S Erdem
Journal:  Acta Haematol       Date:  1965-11       Impact factor: 2.195

4.  Globin gene mapping in normal Hb A2 types of beta-thalassaemia.

Authors:  E Kanavakis; A Metaxotou-Mavromati; C Kattamis; M Aksoy; D J Weatherall; W G Wood
Journal:  Br J Haematol       Date:  1982-05       Impact factor: 6.998

5.  'Silent' beta-thalassaemia caused by a 'silent' beta-chain mutant: the pathogenesis of a syndrome of thalassaemia intermedia.

Authors:  P Fessas; D Loukopoulos; A Loutradi-Anagnostou; G Komis
Journal:  Br J Haematol       Date:  1982-08       Impact factor: 6.998

6.  Genetic regulation of gamma gene expression: study of the interaction of beta-thalassemia with heterocellular HPFH.

Authors:  A M Soummer; U Testa; P Dujardin; A Guerrasio; A Henri; M Gazaix; J Riou; H Rochant; Y Beuzard; J Rosa
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

7.  The use of globin chain electrophoresis in polyacrylamide gels for the quantitation of the G gamma to A gamma ratio in fetal hemoglobin.

Authors:  G D Efremov; B Markovska; N Stojanovski; G Petkov; N Nikolov; T H Huisman
Journal:  Hemoglobin       Date:  1981       Impact factor: 0.849

8.  beta-Thalassemia intermedia homozygous for normal hemoglobin A2 beta-thalassemia. Study in four families.

Authors:  M Aksoy; E Bermek; G Almiş; A Kutlar
Journal:  Acta Haematol       Date:  1982       Impact factor: 2.195

9.  A novel alpha-globin gene arrangement in man.

Authors:  D R Higgs; J M Old; L Pressley; J B Clegg; D J Weatherall
Journal:  Nature       Date:  1980-04-17       Impact factor: 49.962

10.  Inclusion-body beta-thalassemia trait. A form of beta thalassemia producing clinical manifestations in simple heterozygotes.

Authors:  G Stamatoyannopoulos; R Woodson; T Papayannopoulou; D Heywood; S Kurachi
Journal:  N Engl J Med       Date:  1974-04-25       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.